Please provide your email address to receive an email when new articles are posted on . Researchers calculated the likelihood of achieving a BMD T-score of –2.5 or higher with denosumab based on ...
Biochemical outcomes for patients with intermediate-risk, organ-confined prostate cancer treated with I-125 interstitial brachytherapy monotherapy. Background: Decreased BMD is a common side effect of ...
Although bone mineral density (BMD) testing to screen for osteoporosis (BMD T score, −2.50 or lower) is recommended for women 65 years of age or older, there are few data to guide decisions about the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results